期刊
JOURNAL OF FUNCTIONAL FOODS
卷 74, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jff.2020.104159
关键词
Styrax; Obesity; Pancreatic lipase; Inhibitors; Pentacyclic triterpenoid acids (PTAs)
资金
- NSF of China [81860614, 81922070, 81973286, 81773687]
- National Key Research and Development Program of China [2020YFC0845400, 2017YFC1700200, 2017YFC1702000]
- Three-year Action Plan of Shanghai TCM Development [ZY-(2018-2020)-CCCX-5001]
- Program of Shanghai Academic/Technology Research Leader [18XD1403600]
- Shuguang Program - Shanghai Education Development Foundation [18SG40]
- Shanghai Municipal Education Commission
- Qinghai Province
Pancreatic lipase (PL) inhibitor therapy is one of the most effective ways to treat obesity and obesity-associated metabolic disorders. Herein, bioactivity and liquid chromatograph-mass spectrometer (LC-MS) guided fractionation strategy was used to identify the naturally occurring PL inhibitors in Styrax, a popular folk medicine in Asia and Turkey. The results clearly showed that five pentacyclic triterpenoid acids in Styrax displayed strong inhibition on PL, with IC50 values ranging from 0.49 mu M to 6.35 mu M. Further investigations demonstrated that oleanonic acid and betulonic acid (the most two potent PL inhibitors in Styrax) potently inhibited PL in a reversible and mixed inhibition manner, while molecular dynamics simulations showed that these two agents could stably bind at the entrance to the active site of PL. Collectively, our findings revealed the molecular basis for the anti-obesity effects of Styrax, while the newly identified PL inhibitors in this herb could be used for development of novel anti-obesity agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据